Skip to main content
. Author manuscript; available in PMC: 2022 Aug 15.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Sep;29(9):1767–1774. doi: 10.1158/1055-9965.EPI-20-0260

Table 2.

Adjusted* Logistic Regression Model of Factors Associated with having Secondary Breast Cancer compared with Primary Breast Cancer

Characteristics Odds ratios

Race/ethnicity
 Non-Hispanic White Reference
 Non-Hispanic Black 1.35 (1.11, 1.66)
 Hispanic 1.05 (0.91, 1.21)
 Asian/Pacific Islander 0.76 (0.63, 0.92)

Age (years)
 12–24 Reference
 25–29 0.62 (0.23, 1.67)
 30–34 0.79 (0.32, 1.98)
 35–39 1.23 (0.50, 3.01)
 40–44 0.96 (0.39, 2.34)
 45–50 0.42 (0.17, 1.04)

Year of diagnosis
 1988–1994 Reference
 1995–2001 3.47 (2.60, 4.62)
 2002–2008 5.34 (4.02, 7.09)
 2009–2014 6.56 (4.91, 8.75)

Tumor grade
 Grade I Reference
 Grade II 1.29 (1.03, 1.60)
 Grade III 1.76 (1.41, 2.21)
 Undifferentiated 1.82 (1.22, 2.73)

Histology
 Ductal Reference
 Lobular 1.16 (0.97, 1.40)

Tumor size
 T1a: ≤0.5cm Reference
 T1b: >0.5–1cm 0.97 (0.76, 1.24)
 T1c: >1–2cm 0.61 (0.49, 0.76)
 T2: >2–5cm 0.43 (0.34, 0.55)
 T3: >5.00 cm 0.38 (0.28, 0.52)
 Diffuse 0.58 (0.34, 0.99)

Regional lymph node involvement
 Positive 0.58 (0.51, 0.67)
 Negative Reference

ER and PR status
 Positive Reference
 Negative 1.76 (1.52, 2.03)

The estimates of odds ratios for unknown groups are not present.

*

Models adjusted for all variables in the table.

CI=confidence interval; ER=estrogen receptor; PR=progesterone receptor.